Article
Licensed
Unlicensed
Requires Authentication
Haemophilia A: molecular insights
-
Giuseppe Castaldo
Published/Copyright:
April 17, 2007
Abstract
Haemophilia A is the most common inherited bleeding disorder caused by defects in the F8C gene that encodes coagulation factor VIII. This X-linked recessive disorder occurs in approximately 1:5000 males. Haemophilia A is diagnosed based on normal prothrombin time, altered activated partial thromboplastin time and reduced factor VIII activity in plasma. Carrier females are usually asymptomatic and can be identified only by molecular analysis. The most frequent mutations in F8C are intron 22 and 1 inversions, which occur in approximately 50% and 5% of patients, respectively, with a severe phenotype. Large gene deletions are observed in approximately 5% of alleles from patients with severe haemophilia A. The remaining severe cases and all moderate and mild cases result from numerous point mutations and small insertions/deletions, which are de novo mutations in one-third of cases. Thus, molecular diagnosis of carrier status and prenatal diagnosis in families without intron 22 or 1 inversions is based on scanning techniques or gene sequencing. When the disease-causing mutation cannot be identified, molecular diagnosis is performed by linkage analysis of several DNA polymorphic markers linked to F8C. Given the clinical heterogeneity among haemophilic patients, many groups, including our own, have examined the relationships between prothrombotic gene variants and haemophilic phenotype to investigate whether prothrombotic gene variants modify clinical expression of the disease.
Clin Chem Lab Med 2007;45:450–61.
Keywords: factor VIII; haemophilia A; modifier genes; molecular analysis; prothrombotic gene variants
Received: 2006-11-9
Accepted: 2007-1-4
Published Online: 2007-04-17
Published in Print: 2007-04-01
©2007 by Walter de Gruyter Berlin New York
You are currently not able to access this content.
You are currently not able to access this content.
Articles in the same Issue
- Electrophoretic separations of cerebrospinal fluid proteins in clinical investigations
- Haemophilia A: molecular insights
- Quality specifications: self pleasure for clinical laboratories or added value for patient management?
- A724A polymorphism of sarco(endo)plasmic reticulum Ca2+-ATPase 2 (SERCA2) in hypertensive patients
- Associations of common polymorphisms in the thymidylate synthase, reduced folate carrier and 5-aminoimidazole-4-carboxamide ribonucleotide transformylase/inosine monophosphate cyclohydrolase genes with folate and homocysteine levels and venous thrombosis risk
- Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ2 (PPARγ-2) gene is associated with greater insulin sensitivity and decreased risk of type 2 diabetes in an Iranian population
- A novel frameshift mutation of the lecithin:cholesterol acyltransferase (LCAT) gene associated with renal failure in familial LCAT deficiency
- The c.–292C>T promoter polymorphism increases reticulocyte-type 15-lipoxygenase-1 activity and could be atheroprotective
- The genetic polymorphisms of β3-adrenergic receptor (AR) Trp64Arg and β2-AR Gln27Glu are associated with obesity in Chinese male hypertensive patients
- Diagnostic performance of combined specific urinary proteins and urinary flow cytometry in urinary tract pathology
- Diagnostic accuracy of the FIDIS multiplex fluorescent microsphere immunodetection system for anti-extractable nuclear antigen (ENA) antibodies in connective tissue diseases
- Fluorimetric quantitation of citalopram and escitalopram in plasma: developing an express method to monitor compliance in clinical trials
- Free serum cortisol: quantification applying equilibrium dialysis or ultrafiltration and an automated immunoassay system
- Percutaneous coronary intervention-induced variations in systemic parameters of inflammation: relationship with the mode of stenting
- Multicentre physiological reference values for the concentration of creatininium in plasma and diagnostic specificity of glomerular filtration rate estimated with the MDRD equation
- Serum levels of ischemia-modified albumin in healthy volunteers after exercise-induced calf-muscle ischemia
- Reference intervals for follicle-stimulating hormone, luteinizing hormone and prolactin in children and young adults on the bioMérieux Mini-Vidas system
- Limits of usual biochemical alcohol markers in cord blood at term: a fetal/maternal population-based study
- Implementing the Stockholm Conference hierarchy of objective quality criteria in a routine laboratory
- The diffusion of innovations theory could help laboratorians in research translation
- Detection of CYP2D6 polymorphisms *9, *10, and *41 using ARMS-PCR and their allelic frequencies in 400 psychiatric patients
- Toward standardization of carbohydrate-deficient transferrin (CDT) measurements: I. Analyte definition and proposal of a candidate reference method
- Measurement of free thyroxine in laboratory medicine – proposal of measurand definition
Keywords for this article
factor VIII;
haemophilia A;
modifier genes;
molecular analysis;
prothrombotic gene variants
Articles in the same Issue
- Electrophoretic separations of cerebrospinal fluid proteins in clinical investigations
- Haemophilia A: molecular insights
- Quality specifications: self pleasure for clinical laboratories or added value for patient management?
- A724A polymorphism of sarco(endo)plasmic reticulum Ca2+-ATPase 2 (SERCA2) in hypertensive patients
- Associations of common polymorphisms in the thymidylate synthase, reduced folate carrier and 5-aminoimidazole-4-carboxamide ribonucleotide transformylase/inosine monophosphate cyclohydrolase genes with folate and homocysteine levels and venous thrombosis risk
- Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ2 (PPARγ-2) gene is associated with greater insulin sensitivity and decreased risk of type 2 diabetes in an Iranian population
- A novel frameshift mutation of the lecithin:cholesterol acyltransferase (LCAT) gene associated with renal failure in familial LCAT deficiency
- The c.–292C>T promoter polymorphism increases reticulocyte-type 15-lipoxygenase-1 activity and could be atheroprotective
- The genetic polymorphisms of β3-adrenergic receptor (AR) Trp64Arg and β2-AR Gln27Glu are associated with obesity in Chinese male hypertensive patients
- Diagnostic performance of combined specific urinary proteins and urinary flow cytometry in urinary tract pathology
- Diagnostic accuracy of the FIDIS multiplex fluorescent microsphere immunodetection system for anti-extractable nuclear antigen (ENA) antibodies in connective tissue diseases
- Fluorimetric quantitation of citalopram and escitalopram in plasma: developing an express method to monitor compliance in clinical trials
- Free serum cortisol: quantification applying equilibrium dialysis or ultrafiltration and an automated immunoassay system
- Percutaneous coronary intervention-induced variations in systemic parameters of inflammation: relationship with the mode of stenting
- Multicentre physiological reference values for the concentration of creatininium in plasma and diagnostic specificity of glomerular filtration rate estimated with the MDRD equation
- Serum levels of ischemia-modified albumin in healthy volunteers after exercise-induced calf-muscle ischemia
- Reference intervals for follicle-stimulating hormone, luteinizing hormone and prolactin in children and young adults on the bioMérieux Mini-Vidas system
- Limits of usual biochemical alcohol markers in cord blood at term: a fetal/maternal population-based study
- Implementing the Stockholm Conference hierarchy of objective quality criteria in a routine laboratory
- The diffusion of innovations theory could help laboratorians in research translation
- Detection of CYP2D6 polymorphisms *9, *10, and *41 using ARMS-PCR and their allelic frequencies in 400 psychiatric patients
- Toward standardization of carbohydrate-deficient transferrin (CDT) measurements: I. Analyte definition and proposal of a candidate reference method
- Measurement of free thyroxine in laboratory medicine – proposal of measurand definition
